News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
66,952 Results
Type
Article (4475)
Company Profile (15)
Press Release (62462)
Multimedia
Podcasts (5)
Webinars (2)
Section
Business (19568)
Career Advice (125)
Deals (2325)
Drug Delivery (6)
Drug Development (7117)
Employer Resources (3)
FDA (1267)
Job Trends (1151)
News (30057)
Policy (2108)
Tag
Academia (497)
Academic (1)
Accelerated approval (9)
Allergies (13)
Alliances (6748)
ALS (20)
Alzheimer's disease (246)
Antibody-drug conjugate (ADC) (69)
Approvals (1305)
Artificial intelligence (135)
Autoimmune disease (28)
Automation (13)
Bankruptcy (17)
Best Places to Work (973)
BIOSECURE Act (1)
Biosimilars (3)
Biotechnology (11)
Bladder cancer (28)
Brain cancer (21)
Breast cancer (141)
Cancer (1174)
Cardiovascular disease (26)
Career advice (112)
Career pathing (4)
CAR-T (27)
CDC (2)
Cell therapy (61)
Cervical cancer (4)
Clinical research (5465)
Collaboration (341)
Company closure (1)
Compensation (30)
Complete response letters (3)
COVID-19 (385)
CRISPR (22)
C-suite (129)
Cystic fibrosis (19)
Data (1103)
Denatured (1)
Depression (8)
Dermatology (6)
Diabetes (22)
Diagnostics (2901)
Digital health (4)
Diversity (2)
Drug discovery (77)
Drug pricing (2)
Drug shortages (1)
Duchenne muscular dystrophy (18)
Earnings (5280)
Editorial (1)
Employer branding (1)
Employer resources (2)
Events (9274)
Executive appointments (123)
FDA (1552)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (184)
Gene editing (39)
Generative AI (10)
Gene therapy (66)
GLP-1 (63)
Government (418)
Guidances (33)
Healthcare (1687)
HIV (4)
Huntington's disease (1)
IgA nephropathy (6)
Immunology and inflammation (21)
Immuno-oncology (10)
Indications (23)
Infectious disease (438)
Inflammatory bowel disease (24)
Influenza (26)
Intellectual property (26)
Interviews (11)
IPO (923)
IRA (1)
Job creations (204)
Job search strategy (101)
JPM (3)
Kidney cancer (4)
Labor market (1)
Layoffs (20)
Leadership (2)
Legal (248)
Liver cancer (10)
Longevity (7)
Lung cancer (171)
Lymphoma (68)
Machine learning (13)
Management (1)
Manufacturing (43)
MASH (11)
Medical device (510)
Medtech (515)
Mergers & acquisitions (1489)
Metabolic disorders (69)
mRNA (18)
Multiple sclerosis (7)
Neurodegenerative disease (52)
Neuropsychiatric disorders (3)
Neuroscience (365)
NextGen: Class of 2026 (395)
Non-profit (417)
Now hiring (10)
Obesity (36)
Opinion (22)
Ovarian cancer (17)
Pain (16)
Pancreatic cancer (57)
Parkinson's disease (29)
Partnered (3)
Patents (44)
Patient recruitment (51)
Peanut (5)
People (7451)
Pharmaceutical (1)
Phase 1 (2302)
Phase 2 (2508)
Phase 3 (1481)
Pipeline (959)
Policy (5)
Postmarket research (107)
Preclinical (1732)
Press Release (18)
Prostate cancer (57)
Psychedelics (3)
Radiopharmaceuticals (63)
Rare diseases (72)
Real estate (457)
Recruiting (1)
Regulatory (1860)
Reports (7)
Research institute (619)
Resumes & cover letters (15)
Rett syndrome (5)
RNA editing (4)
RSV (4)
Schizophrenia (5)
Series A (30)
Series B (12)
Sickle cell disease (3)
Spinal muscular atrophy (21)
Sponsored (3)
Startups (461)
Stomach cancer (1)
Supply chain (3)
Tariffs (1)
The Weekly (4)
Vaccines (48)
Venture capital (4)
Weight loss (16)
Women's health (7)
Worklife (1)
Date
Today (16)
Last 7 days (79)
Last 30 days (310)
Last 365 days (2963)
2026 (1251)
2025 (3018)
2024 (3421)
2023 (4197)
2022 (5476)
2021 (5637)
2020 (5209)
2019 (3593)
2018 (2705)
2017 (3405)
2016 (3406)
2015 (3996)
2014 (2757)
2013 (2314)
2012 (2478)
2011 (2650)
2010 (2205)
Location
Africa (61)
Alabama (3)
Alaska (1)
Arizona (22)
Asia (3515)
Australia (737)
California (1343)
Canada (293)
China (186)
Colorado (37)
Connecticut (62)
Delaware (64)
Europe (10209)
Florida (148)
Georgia (9)
Idaho (3)
Illinois (116)
India (9)
Indiana (52)
Iowa (2)
Japan (63)
Kansas (6)
Kentucky (2)
Louisiana (2)
Maine (3)
Maryland (127)
Massachusetts (947)
Michigan (23)
Minnesota (54)
Missouri (17)
Montana (2)
Nevada (1)
New Hampshire (2)
New Jersey (226)
New Mexico (7)
New York (404)
North Carolina (101)
North Dakota (4)
Northern California (707)
Ohio (41)
Oklahoma (1)
Oregon (4)
Pennsylvania (193)
Puerto Rico (1)
Rhode Island (4)
South America (76)
South Carolina (1)
Southern California (472)
Tennessee (22)
Texas (352)
United States (4533)
Utah (146)
Virginia (19)
Washington D.C. (6)
Washington State (119)
Wisconsin (39)
66,952 Results for "diasorin molecular".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Funding
Degron adds $40M to series A, supporting immunology plans for molecular glue platform
Degron Therapeutics will have stiff competition in immunology, as Novartis inked a $5.7 billion agreement with Monte Rosa Therapeutics last year to develop molecular glues for undisclosed immune-mediated conditions.
May 14, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Incyte and Genesis Expand Molecular AI Collaboration to Accelerate Drug Discovery
May 20, 2026
·
5 min read
Press Releases
Degron Therapeutics Closes $40 Million Series A Extension to Support Molecular Glue Degrader Clinical Development
May 14, 2026
·
5 min read
Press Releases
Cubit Diagnostics Closes SAFE Financing to Advance Molecular Assay Development and Expand Immunoassay Menu
May 8, 2026
·
2 min read
Press Releases
Seek Labs Awarded U.S. Patent for Isothermal Molecular Amplification Chemistry Designed for Decentralized Testing
May 8, 2026
·
3 min read
Press Releases
Hiteck Pharmaceutical and LexBio to Present Findings for HT016 VAV1 Molecular Glue Degrader at AAI 2026
May 13, 2026
·
1 min read
Deals
Roche sticks with C4T, adding up to $1B for molecular glue partnership
Roche is jumping into degrader-antibody conjugates, a modality that in recent years has attracted investments from Merck KGaA and Bristol Myers Squibb.
April 9, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Moolec Science Announces Breakthrough in Molecular Farming With Successful Expression of Bovine Myoglobin in Pea Seeds
April 7, 2026
·
4 min read
Press Releases
Mimulus and GenScript Partner to Scale the World’s First Zero-Watt Molecular Archive Infrastructure for the AI Era
April 9, 2026
·
5 min read
Press Releases
Foundation Medicine to Strengthen Monitoring Portfolio with SAGA Diagnostics’ Tumor-Informed Molecular Residual Disease (MRD) Platform
April 17, 2026
·
5 min read
1 of 6,696
Next
